Susceptibilities of Legionella spp. to Newer Antimicrobials In Vitro

AUTOR(ES)

Schülin, T.

FONTE

American Society for Microbiology

RESUMO

The in vitro activities of 13 antimicrobial agents against 30 strains of Legionella spp. were determined. Rifapentine, rifampin, and clarithromycin were the most potent agents (MICs at which 90% of isolates are inhibited [MIC90s], ≤0.008 μg/ml). The ketolide HMR 3647 and the fluoroquinolones levofloxacin and BAY 12-8039 (MIC90s, 0.03 to 0.06 μg/ml) were more active than erythromycin A or roxithromycin. The MIC90s of dalfopristin-quinupristin and linezolid were 0.5 and 8 μg/ml, respectively. Based on class characteristics and in vitro activities, several of these agents may have potential roles in the treatment of Legionella infections.

Documentos Relacionados

• In Vitro Susceptibilities of 27 Rickettsiae to 13 Antimicrobials
• In vitro susceptibilities of Nocardia species to newer antimicrobial agents.
• In Vitro Susceptibilities of Burkholderia mallei in Comparison to Those of Other Pathogenic Burkholderia spp.
• Mycotic Keratitis Due to Curvularia senegalensis and In Vitro Antifungal Susceptibilities of Curvularia spp.
• In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.